You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 8 No. 3, March 1963 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (7)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Neurologic Status of Patients with Liver Disease

Correlation with Cerebrospinal Fluid and Blood Ammonia Content

CARL B. BOOTH, M.D.; JOHN G. SWADEY, M.D.; ROSA E. FIOL, M.D.; BERNARD KLEIN, Ph.D.; JULIA C. HALL, Ph.D.

Arch Neurol. 1963;8(3):257-263.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

A highly suggestive correlation between blood ammonia levels on the one hand and alterations of mental status and characteristic involuntary movements on the other in patients with liver disease has been reported by many workers.1-5 Complete reviews of our current knowledge of ammonia metabolism have been published recently by Bessman6 and by Chalmers.7 The concept of a relationship of blood and cerebrospinal fluid (CSF) ammonia levels to neurologic findings apart from mental changes and the typical hepatic "flap," however, has received relatively little attention. In particular, the correlation of specific findings in either the neurologic, general physical, or laboratory examinations of patients with liver disease, with blood or CSF ammonia levels has not, to our knowledge, been the subject of any rigorous study. The principal purpose of this report is to determine whether the ammonia levels of blood and cerebrospinal fluid of patients with liver disease have . . . [Full Text PDF of this Article]


Author Affiliations

BRONX, N.Y.

From the Neurological Section, The Medical and Laboratory Services, and the Psychology Section of the Bronx Veterans Administration Hospital, 130 W. Kingsbridge Road, Bronx 68, N.Y. and from the Division of Neuropathology of the Department of Pathology, College of Physicians and Surgeons, Columbia University.


Footnotes

Received for publication Oct. 8, 1962.

Assistant Clinical Professor of Neurology, College of Physicians and Surgeons, Columbia University, N.Y. (Dr. Booth), and Visiting Assistant Professor of Biochemistry, Albert Einstein College of Medicine, Yeshiva University, N.Y. (Dr. Klein).

This work was supported in part by Neuropathology Training Grant 5B 11-58 from the National Institute of Neurological Diseases and Blindness, United States Public Health Service.

One patient had adenocarcinoma of the liver in addition to hemochromatosis.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1963 American Medical Association. All Rights Reserved.